Ratings AECI Ltd OTC Markets

Equities

AECLY

US0010122028

Delayed OTC Markets Other stock markets 06:40:00 29/11/2023 am IST			5-day change	1st Jan Change
7.9 ^USD	-.--%		-.--%	-.--%

28/02	Transcript : AECI Ltd, 2023 Earnings Call, Feb 28, 2024
27/02	AECI Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Its low valuation, with P/E ratio at 6.64 and 5.19 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company shows low valuation levels, with an enterprise value at 0.22 times its sales.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
This company will be of major interest to investors in search of a high dividend stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
AECI LTD	-.--%	55Cr	-
ECOLAB INC.	+17.23%	6.62TCr	A-
SIKA AG	+1.57%	4.92TCr	A-
GIVAUDAN SA	+16.99%	4.17TCr	B+
FUJIFILM HOLDINGS CORPORATION	+22.44%	2.62TCr	A-
EMS-CHEMIE HOLDING AG	+12.56%	1.98TCr	C+
CELANESE CORPORATION	+3.48%	1.75TCr	B+
POSCO FUTURE M CO., LTD.	-23.12%	1.56TCr	A-
ALBEMARLE CORPORATION	-6.73%	1.55TCr	C+
SYMRISE AG	+2.77%	1.54TCr	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes